Lv51
980 积分 2025-12-12 加入
Sleep apnoea and ischaemic stroke: current knowledge and future directions
17天前
已完结
IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial
30天前
已完结
The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial
1个月前
已完结
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment
1个月前
已完结
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment
1个月前
已完结
Drug-induced hyperinsulinemic hypoglycemia: An update on pathophysiology and treatment
2个月前
已完结
Hyperinsulinemic Hypoglycemia
2个月前
已完结
Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 trial
2个月前
已完结
Orforglipron Added to Titrated Insulin Glargine in Type 2 Diabetes: The ACHIEVE-5 Randomized Clinical Trial
2个月前
已关闭
Hyponatraemia-treatment standard 2024
3个月前
已完结
皖公网安备34019202002308
